According to a new report by Expert Market Research, the Infusion Therapy Market was valued at USD 54.27 Billion in 2025 and is projected to grow at a CAGR of 6.8% to reach USD 104.78 Billion by 2035.
The global is expanding significantly due to increasing demand for minimally invasive drug delivery systems, rising prevalence of chronic diseases, and technological advancements in infusion devices. Expert Market Research highlights that the growing adoption of home healthcare and ambulatory services is further accelerating market penetration across developed and emerging economies.
Key market drivers include the rising incidence of cancer, diabetes, and autoimmune disorders, which require long-term infusion-based treatments. Additionally, improvements in hospital infrastructure and increased government healthcare spending are strengthening demand. Expert Market Research also emphasizes that innovations in smart infusion pumps and safety-enhanced delivery systems are reshaping clinical practices globally. Increasing preference for targeted therapies and biologics is further supporting steady market expansion.
Download a Free Sample Report Including TOC
The market outlook remains highly positive, with strong investment in healthcare modernization and digital infusion monitoring systems. Expert Market Research projects sustained growth across all major regions, driven by rising patient awareness and technological integration in drug delivery systems. The Infusion Therapy Market is expected to witness strong momentum in both inpatient and outpatient care settings over the forecast period.
Market Overview
The Infusion Therapy Market plays a critical role in modern healthcare systems by enabling precise administration of medications, fluids, and nutrients directly into the bloodstream. It is widely used across oncology, gastroenterology, and infectious disease management. Expert Market Research notes that increasing preference for home-based infusion therapy is reducing hospital burden and improving patient comfort. The market is characterized by continuous innovation in infusion pumps, tubing systems, and safety accessories.
Market Size & Forecast Analysis: Expert Market Research Projections
| Year | Market Value (USD Million) |
|---|---|
| 2025 | 54270.00 |
| 2026 | 57960.36 |
| 2027 | 61902.06 |
| 2028 | 66111.40 |
| 2029 | 70606.95 |
| 2030 | 75408.22 |
| 2031 | 80535.22 |
| 2032 | 86011.60 |
| 2033 | 91852.40 |
| 2034 | 98099.00 |
| 2035 | 104769.70 |
According to Expert Market Research, the Infusion Therapy Market was valued at 54.27 Billion in 2025 and is projected to grow at a CAGR of 6.8% to reach 104.78 Billion by 2035.
Macroeconomic & Industry Linkage Analysis
The Infusion Therapy Market is closely linked with global healthcare expenditure, demographic aging, and rising prevalence of chronic illnesses. Increasing hospital investments and insurance coverage expansion are positively influencing demand for infusion-based treatments. Expert Market Research highlights that supply chain improvements in medical devices and pharmaceuticals are also contributing to market stability.
Furthermore, macroeconomic factors such as government healthcare reforms and public-private partnerships are enhancing access to advanced infusion technologies. The integration of digital health systems is improving treatment accuracy and patient monitoring efficiency across healthcare facilities.
Key Growth Drivers
- Rising Chronic Disease Burden: Increasing cases of cancer, diabetes, and immune disorders are driving infusion therapy demand.
- Technological Advancements: Smart infusion pumps and automated drug delivery systems are improving safety and efficiency.
- Expansion of Home Healthcare: Patients increasingly prefer home-based treatment solutions.
- Healthcare Infrastructure Growth: Hospital expansion in emerging economies supports adoption.
- Rising Biologics Use: Growth in targeted therapies increases reliance on infusion systems.
Market Trends
One of the key trends in the Infusion Therapy Market is the shift toward portable and wearable infusion devices. Expert Market Research observes that healthcare providers are increasingly adopting wireless monitoring systems for real-time infusion tracking. Another trend is the integration of AI-based drug delivery optimization systems, which enhance treatment precision.
Additionally, rising demand for home infusion therapy is reshaping service delivery models, reducing hospital congestion and improving patient quality of life.
Market Challenges & Risk Factors
High device costs and maintenance requirements remain key barriers for adoption in low-income regions. Regulatory complexities and stringent approval processes can also delay product launches. Expert Market Research notes that cybersecurity risks in connected infusion devices are emerging as a critical concern.
Supply chain disruptions and raw material price volatility further impact manufacturing efficiency and profitability across the sector.
Market Opportunities & White Space Areas
Emerging economies present significant growth opportunities due to improving healthcare infrastructure and rising patient awareness. Development of cost-effective infusion devices for outpatient care is a major opportunity area. Expert Market Research identifies digital infusion monitoring and AI-enabled drug delivery systems as high-growth segments.
Expansion of home healthcare services and telemedicine integration further open new market avenues for stakeholders.
Value Chain & Supply Chain Analysis
The infusion therapy value chain includes raw material suppliers, device manufacturers, distributors, healthcare providers, and end users. Efficient coordination between these segments ensures timely delivery of infusion systems and consumables. Expert Market Research highlights that globalization of medical device supply chains has improved accessibility but also increased dependency on key manufacturing hubs.
Market Segmentation Analysis
Breakup by Product
- Infusion Pumps
- Infusion Sets
- Accessories
Breakup by Indication
- Cancer
- Gastrointestinal Disorders
- Congestive Heart Failure
- Rheumatoid Arthritis
- Hemophilia
- Immune Deficiencies
- Others
Breakup by Therapy Type
- Antibiotic/Antiviral
- Anti-Coagulation
- Anti-Emetics
- Blood Component Stimulating Factor
- Chemotherapy
- Nutrition
- Hydration
- Pain Management
- Others
Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers (ASCs)
- Homecare Settings
- Others
Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
| Company | Headquarters | Key Focus Area |
|---|---|---|
| B. Braun SE | Germany | Infusion systems and hospital care solutions |
| Medtronic plc | Ireland | Advanced medical devices and infusion technologies |
| Becton, Dickinson and Company | USA | Medical devices and infusion safety systems |
| ICU Medical | USA | Infusion therapy and vascular access devices |
| Baxter AG | USA | Hospital and renal care infusion solutions |
| Terumo Medical Corporation | Japan | Infusion and transfusion systems |
| Fresenius Kabi | Germany | Clinical nutrition and infusion therapies |
| Cardinal Health | USA | Healthcare supply chain and infusion products |
| Mediprim GmbH | Germany | Medical infusion and healthcare devices |
| Polymedicure | India | Disposable infusion and medical consumables |
Frequently Asked Questions (FAQs)
1. What is the current size of the Infusion Therapy Market?
The market was valued at USD 54.27 Billion in 2025.
2. What is the projected CAGR of the Infusion Therapy Market?
The market is projected to grow at a CAGR of 6.8% from 2026 to 2035.
3. Which region dominates the Infusion Therapy Market?
North America holds a significant share due to advanced healthcare infrastructure.
4. Who are the key players in the Infusion Therapy Market?
B. Braun SE, Medtronic plc, Becton, Dickinson and Company, ICU Medical, Baxter AG, Terumo Medical Corporation, Fresenius Kabi, Cardinal Health, Mediprim GmbH, Polymedicure.
5. What are the major growth drivers of the Infusion Therapy Market?
Rising chronic diseases, technological advancements, and home healthcare expansion.
6. What are the key segments of the Infusion Therapy Market?
Product, indication, therapy type, end user, and region.
7. What challenges does the Infusion Therapy Market face?
High costs, regulatory barriers, and cybersecurity risks.
8. What is the forecast value of the Infusion Therapy Market by 2035?
The market is expected to reach USD 104.78 Billion by 2035.
"}
About Us:
Expert Market Research is a global market intelligence and consulting platform by Claight delivering data-driven insights across commodities, chemicals, energy, and industrial markets. We design our research to support businesses, analysts, investors, and procurement teams in understanding price trends, supply-demand dynamics, competitive landscapes, gaining competitive intelligence, benchmarking best practices, and developing long-term market outlooks.
Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.
Media Contact:
Company Name: Claight Corporation
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com
